Table 4.
Details of the patients with BOOP syndrome (n = 16)
| Patient no. | Endocrine therapy | CT | Lung V20(%) | Time after RT (mo) | Symptoms | Treatment | |
|---|---|---|---|---|---|---|---|
| 1 | BCT | TAM | - | 7.9 | 7.6 | cough | antitussive, |
| LHRH-agonist | antibiotic | ||||||
| 2 | BCT | TAM | - | 6.0 | 4.0 | cough, pyrexia, | steroid, |
| decreased SpO2 | antibiotic | ||||||
| 3 | BCT | TAM | - | 5.0 | 5.3 | cough, pyrexia, | antitussive, |
| fatigue | antibiotic | ||||||
| 4 | BCT | TAM | - | 8.6 | 5.1 | cough, pyrexia | antitussive, |
| antibiotic | |||||||
| 5 | BCT | TAM | - | 8.1 | 2.3 | cough | antitussive, |
| steroid | |||||||
| 6 | BCT | ANA | - | 4.4 | 5.0 | cough, fatuigue | antibiotic |
| 7 | BCT | ANA | - | 6.0 | 4.7 | cough | antitussive, |
| antibiotic | |||||||
| 8 | BCT | ANA | - | 5.1 | 3.0 | cough, pyrexia | antitussive |
| 9 | BCT | ANA | - | 9.0 | 4.5 | cough | antitussive, |
| antibiotic | |||||||
| 10 | BCT | ANA | - | 4.8 | 3.1 | cough, fatigue | antitussive, |
| antibiotic | |||||||
| 11 | BCT | ANA | AC | 6.8 | 8.6 | cough | antitussive |
| PAC | |||||||
| 12 | BCT | - | CAF | 5.6 | 6.0 | cough | antibiotic |
| 13 | PMRT | TAM | CAF | 17.7 | 3.3 | cough, pyrexia | antitussive, |
| PAC | antibiotic | ||||||
| 14 | PMRT | ANA | CAF | 13.4 | 7.4 | cough | antitussive, |
| PAC | antibiotic | ||||||
| 15 | PMRT | - | CAF | 15.6 | 3.9 | cough, pyrexia | antibiotic |
| PAC | |||||||
| 16 | PMRT | - | CAF | 22.0 | 5.3 | cough, pyrexia, | antitussive |
| PAC | fatigue |
Abbreviations
CT Chemotherapy.
TAM Tamoxifen.
ANA Anastrozole
AC Doxorubicin, Cyclophosphamide.
PAC Paclitaxel.
CAF Cyclophosphamide, Doxorubicin and Fluorouracil.